|
0 Companies |
|
0 Products |
|
0 Products |
|
1 Mechanism of Action |
|
0 Trials |
|
15 News |
|
- | Trial completion, Enrollment change: Silo Versus Primary Closure for Gastroschisis (clinicaltrials.gov) - Jan 11, 2019
P=N/A, N=38, Completed, Sponsor: Children's Mercy Hospital Kansas City
Recruiting --> Completed | N=100 --> 38
- | Enrollment change, Trial termination, Trial primary completion date: Sutureless vs Sutured Gastroschisis Closure (clinicaltrials.gov) - Oct 13, 2017
P=N/A, N=39, Terminated, Sponsor: Stanford University
Recruiting --> Completed | N=100 --> 38 N=54 --> 39 | Recruiting --> Terminated | Trial primary completion date: Nov 2013 --> Jun 2015; Enrollment difficulty
- | Phase classification, Trial termination, Trial primary completion date: Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine Care (clinicaltrials.gov) - Jul 13, 2017
P=N/A, N=21, Terminated, Sponsor: Baylor College of Medicine
N=54 --> 39 | Recruiting --> Terminated | Trial primary completion date: Nov 2013 --> Jun 2015; Enrollment difficulty Phase classification: P2/3 --> P=N/A | Active, not recruiting --> Terminated | Trial primary completion date: Apr 2017 --> Jan 2017; Study was stoped according to preliminary analysis.
- | Trial completion, Enrollment change, Trial primary completion date: Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair (clinicaltrials.gov) - Jun 28, 2017
P=N/A, N=4, Completed, Sponsor: Duke University
Phase classification: P2/3 --> P=N/A | Active, not recruiting --> Terminated | Trial primary completion date: Apr 2017 --> Jan 2017; Study was stoped according to preliminary analysis. Recruiting --> Completed | N=20 --> 4 | Trial primary completion date: Sep 2018 --> Nov 2016
- Enrollment closed, Enrollment change: Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine Care (clinicaltrials.gov) - Sep 22, 2016
P2/3, N=21, Active, not recruiting, Sponsor: Baylor College of Medicine
Recruiting --> Completed | N=20 --> 4 | Trial primary completion date: Sep 2018 --> Nov 2016 Recruiting --> Active, not recruiting | N=86 --> 21
- Trial primary completion date: Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine Care (clinicaltrials.gov) - Jul 20, 2016
P2/3, N=86, Recruiting, Sponsor: Baylor College of Medicine
Recruiting --> Active, not recruiting | N=86 --> 21 Trial primary completion date: Apr 2016 --> Apr 2017
- Enrollment change, Trial termination: Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants (clinicaltrials.gov) - Nov 25, 2015
P=N/A, N=48, Terminated, Sponsor: University of Miami
Trial primary completion date: Apr 2016 --> Apr 2017 N=120 --> 48 | Recruiting --> Terminated; Difficulty in recruiting patients
- New trial: Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=20, Recruiting, Sponsor: Duke University
- Trial primary completion date: Silo Versus Primary Closure for Gastroschisis (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=100, Recruiting, Sponsor: Children's Mercy Hospital Kansas City
N=120 --> 48 | Recruiting --> Terminated; Difficulty in recruiting patients Trial primary completion date: Jan 2014 --> Jan 2018
- Trial primary completion date: Probiotics in Infants With Gastroschisis (clinicaltrials.gov) - Jan 26, 2015
P=N/A, N=24, Recruiting, Sponsor: University of California, Davis
Trial primary completion date: Jan 2014 --> Jan 2018 Trial primary completion date: Mar 2013 --> Mar 2015
- Enrollment change, Trial termination, Trial primary completion date: Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure (clinicaltrials.gov) - Dec 24, 2014
P1/2, N=13, Terminated, Sponsor: Alberta Children's Hospital
Trial primary completion date: Mar 2013 --> Mar 2015 N=25 --> 13 | Suspended --> Terminated | Trial primary completion date: Jul 2016 --> Aug 2014; GLP-2 Drug product stability concerns
- Trial suspension, Trial primary completion date: Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure (clinicaltrials.gov) - Oct 22, 2014
P1/2, N=25, Suspended, Sponsor: Alberta Children's Hospital
N=25 --> 13 | Suspended --> Terminated | Trial primary completion date: Jul 2016 --> Aug 2014; GLP-2 Drug product stability concerns Recruiting --> Suspended | Trial primary completion date: Dec 2015 --> Jul 2016
- Enrollment change: Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure (clinicaltrials.gov) - Mar 9, 2014
P1/2, N=25, Recruiting, Sponsor: Alberta Children's Hospital
Recruiting --> Suspended | Trial primary completion date: Dec 2015 --> Jul 2016 N=32 --> 25
- || New P2/3 trial: Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine Care (clinicaltrials.gov) - Jun 20, 2013
P2/3, N=86, Recruiting, Sponsor: Baylor College of Medicine
- New P1/2 trial: Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure (clinicaltrials.gov) - Apr 5, 2012
P1/2, N=25, Recruiting, Sponsor: Alberta Children's Hospital